Pronóstico del mercado de descubrimiento de anticuerpos en América del Norte hasta 2030: análisis regional, por tipo de anticuerpo (anticuerpos monoclonales, anticuerpos policlonales y otros), naturaleza (humano y humanizado, quimérico y murino), servicios (exhibición de fagos, hibridoma, animal transgénico, célula única y levadura) y usuario final (empresas farmacéuticas y de biotecnología, laboratorios de investigación y otros)
El aumento de las inversiones en investigación y desarrollo impulsa el mercado de descubrimiento de anticuerpos de América del Norte
Los anticuerpos, incluidos los monoclonales y policlonales, encuentran aplicaciones en institutos y organizaciones académicas, de investigación y farmacéuticas, donde se utilizan en varias actividades de I+D relacionadas con el desarrollo de fármacos y biomarcadores, y otros productos de diagnóstico clínico y terapéutico. Las pequeñas y medianas empresas se centran en aumentar sus inversiones en I+D cada año. En abril de 2020, el gobierno federal de los EE. UU. asignó US$ 3.5 mil millones a la Autoridad de Investigación y Desarrollo Avanzado Biomédico (BARDA) en virtud de su Ley de Ayuda, Alivio y Seguridad Económica por Coronavirus (CARES) para brindar apoyo financiero para la fabricación, producción y adquisición de vacunas, diagnósticos, terapias e ingredientes farmacéuticos activos (API) de moléculas pequeñas, entre otros. Además, Bio-Rad, una empresa farmacéutica, proporciona 10.000 anticuerpos, junto con antígenos, reactivos y tampones, para desarrollar pruebas de diagnóstico in vitro. Por lo tanto, las crecientes inversiones de las empresas farmacéuticas en actividades de investigación y desarrollo relacionadas con el descubrimiento de anticuerpos para desarrollar mejores opciones de tratamiento para diversas enfermedades impulsan el crecimiento del mercado de descubrimiento de anticuerpos.
Descripción general del mercado de descubrimiento de anticuerpos de América del Norte
El mercado de descubrimiento de anticuerpos de América del Norte está segmentado en EE. UU., Canadá y México. El crecimiento del mercado en la región está determinado por un aumento en la prevalencia del cáncer, la fuerte presencia de la industria de investigación de anticuerpos y los avances tecnológicos en el sector de I+D. Según la Sociedad Estadounidense del Cáncer, en 2020 se diagnosticaron ~1,8 millones de nuevos casos de cáncer y se registraron ~606.520 muertes relacionadas con el cáncer en los EE. UU. Esto refuerza la necesidad de anticuerpos terapéuticos, lo que impulsa el crecimiento del mercado de descubrimiento de anticuerpos. Un aumento en la financiación permite además el desarrollo de nuevas tecnologías, la puesta en común de recursos y experiencia entre países y organizaciones, y la realización de trabajos de investigación sobre los tratamientos con anticuerpos existentes. Esto ha llevado a una mejor comprensión del sistema inmunológico y al desarrollo de anticuerpos efectivos y específicos. Además, el aumento de la financiación permite a los científicos realizar ensayos clínicos a gran escala que son obligatorios para evaluar la eficacia de un anticuerpo en particular.
Ingresos y pronóstico del mercado de descubrimiento de anticuerpos de América del Norte hasta 2030 (miles de millones de dólares estadounidenses)
Segmentación del mercado de descubrimiento de anticuerpos de América del Norte
El mercado de descubrimiento de anticuerpos de América del Norte se clasifica en tipo de anticuerpo, naturaleza, servicios, usuario final y país.
Según el tipo de anticuerpo, el mercado de descubrimiento de anticuerpos de América del Norte se segmenta en anticuerpos monoclonales, anticuerpos policlonales y otros. El segmento de anticuerpos monoclonales tuvo la mayor participación en el mercado de descubrimiento de anticuerpos de América del Norte en 2022.
En términos de naturaleza, el mercado de descubrimiento de anticuerpos de América del Norte se segmenta en humano y humanizado, quimérico y murino. El segmento humano y humanizado tuvo la mayor participación en el mercado de descubrimiento de anticuerpos de América del Norte en 2022.
Por servicios, el mercado de descubrimiento de anticuerpos de América del Norte se divide en visualización de fagos, hibridoma, animal transgénico, célula única y visualización de levadura. El segmento de visualización de fagos tuvo la mayor participación en el mercado de descubrimiento de anticuerpos de América del Norte en 2022.
Según el usuario final, el mercado de descubrimiento de anticuerpos de América del Norte se clasifica en empresas farmacéuticas y de biotecnología, laboratorios de investigación y otros. El segmento de empresas farmacéuticas y de biotecnología tuvo la mayor participación en el mercado de descubrimiento de anticuerpos de América del Norte en 2022.
Según el país, el mercado de descubrimiento de anticuerpos de América del Norte se clasifica en EE. UU., Canadá y México. Estados Unidos dominó la participación de mercado de descubrimiento de anticuerpos en América del Norte en 2022.
Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Bruker Cellular Analysis Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, NanoCellect Biomedical Inc y Biocytogen Pharmaceuticals Beijing Co Ltd. son algunas de las empresas líderes que operan en el mercado de descubrimiento de anticuerpos de América del Norte.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Antibody Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Investments in Research & Development
4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
4.2.1 High Cost of Production
4.3 Market Opportunities
4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:
5. Antibody Discovery Market - North America Market Analysis
5.1 North America Antibody Discovery Market Revenue (US$ Million), 2020-2030
6. North America Antibody Discovery Market Analysis - by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Antibody Discovery Market Analysis - by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Antibody Discovery Market Analysis - by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Antibody Discovery Market Analysis - by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Antibody Discovery Market - Country Analysis
10.1 North America Market Overview
10.1.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
10.1.1.1 US
10.1.1.1.1 Overview
10.1.1.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 United States: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 United States: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 United States: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Canada
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Canada: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Canada: Antibody Discovery Market Breakdown, by End User
10.1.1.3 Mexico
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 Mexico: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Biolabs Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bruker Cellular Analysis Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BioDuro LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Sartorius AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Aragen Life Sciences Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Twist Bioscience Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NanoCellect Biomedical Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Biocytogen Pharmaceuticals Beijing Co Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. North America Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 16. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 17. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. North America Antibody Discovery Market Segmentation, by Country
Figure 2. North America Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. North America Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. US: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- Creative Biolabs Inc
- Evotec SE
- Bruker Cellular Analysis Inc
- BioDuro LLC
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- NanoCellect Biomedical Inc
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.